Switzerland / Building a Health Data Ecosystem
Although Switzerland is ahead of many of its competitors in Europe on levels of healthcare innovation, one…
EUROPE
Switzerland / Swissmedic New Drug Approvals 2020
Regarded as one of the world’s leading regulatory bodies, Swissmedic stands alongside its equivalents in Europe,…
Talent / Biogen's Swiss Head on Benefits of Diverse Experience & Building an Entrepreneurial Team
A trained physician with several years of practice under her belt, Katharina Gasser then moved into clinical…
France / ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal; AntiVax Struggles; Servier’s Neurology Push
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19…
Norway / The Woman Flying the Flag for Norwegian Pharma
Small in terms of market size and without the historic life sciences footprint of neighbouring Sweden and Denmark,…
Norway / Photocure: Swimming in the “Blue Ocean” of Oncology Drug-Device Combinations
Photodynamic therapy (PDT) firm Photocure is probably Norway’s most significant recent international healthcare…
Norway / Neuroscience: Nobel Prizes & Enduring Focus
Norway has long held a strong international position in neuroscience and is home to Professors May-Britt and Edvard…
Switzerland / Moving the Needle on Gender Diversity in Pharma Leadership
While Switzerland has Europe’s second-highest proportion of women in the workforce, it trails global…
Data / Switzerland Innovation & Competitiveness Snapshot 2020
In just a few years, Switzerland has fallen from first to fifth place in the Global Competitiveness Index. The…
In Conversation
Roman Dusil – General Manager, Pierre Fabre Laboratories Czech Republic & Slovakia
Roman Dusil, GM of Pierre Fabre Laboratories in the Czech Republic and Slovakia, shares how the Czech affiliate is ahead of Pierre Fabre’s global transformation of the convergence between the dermo-cosmetic and pharmaceutical verticals. In dermo-cosmetics, Dusil explains the dynamics of the Czech pharmacy market and emphasizes the company’s efforts to catch up with its competitors in the digital space. In…
Latest Reports
Focus on Belgium
Belgium Appoints ‘Corona Commissioner’ to Coordinate…
The new Belgian government has moved to streamline its response to the COVID-19…
The Long Read: Belgium – The Multifaceted
Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the…
Read more from Belgium >>
Focus on Norway
The Long Read / Norway: Unlocking Potential
Equality has long been a deeply held ideal in Norway, where the concept of…
Photocure: Swimming in the “Blue Ocean” of Oncology…
Photodynamic therapy (PDT) firm Photocure is probably Norway’s most…
Read more from Norway >>
Focus on Switzerland
Building a Health Data Ecosystem in Switzerland
Although Switzerland is ahead of many of its competitors in Europe on levels of…
Biogen’s Swiss Head on Benefits of Diverse Experience…
A trained physician with several years of practice under her belt, Katharina…
Read more from Switzerland >>
Focus on France
France: ‘Humiliation’ & the Sanofi-Pfizer Vaccine…
The latest from French pharma where Sanofi has inked a deal to produce 125…
France: Mid-2021 for Sanofi COVID-19 Vaccine; 1 Million…
A roundup of the latest stories from French pharma, including the progress of…
Read more from France >>
Cell & Gene Therapy Launches / Zolgensma® in Belgium: Lessons Learned
In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy…
Malta: The Next Powerhouse in Medical Cannabis?
One area in which the island nation of Malta has been a first mover in embracing disruption has been its…
Oncology / Switzerland: Fresh Tactics in the War on Cancer
With cancer now causing one in eight deaths globally and, in Europe, even outpacing serious cardiovascular…
Spain / Pharma News Roundup September 2020
A roundup of the latest news from Spanish pharma, including J&J’s COVID-19 vaccine trial, the latest…
UK / MSD to Build USD 1.3 Billion London Research Hub in Boon for Post-Brexit Britain
US Merck (MSD globally) is following through on a 2017 commitment to invest in a new early research hub in central…
Internationalization / Chiesi Moves into Rare Diseases & the US Market
Italian mid-cap firm Chiesi is continuing its expansion in the USA market with the launch of a Boston-based…